228 studies found for:
Non-Alcoholic Steatohepatitis
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Completed |
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis
|
||||
| 22 | Completed |
Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis
|
||||
| 23 | Completed |
Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis
|
||||
| 24 | Unknown † |
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
|
||||
| 25 | Terminated |
Rifaximin in Fatty Liver Disease
|
||||
| 26 | Completed |
Effects of Alanine in Patients With Nonalcoholic Steatohepatitis
|
||||
| 27 | Completed |
Betaine in Patients With Nonalcoholic Steatohepatitis
|
||||
| 28 | Completed |
Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis
|
||||
| 29 | Completed |
Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)
|
||||
| 30 | Recruiting |
GS-6624 in the Treatment of Liver Fibrosis in Subjects With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
|
||||
| 31 | Withdrawn |
Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
|
||||
| 32 | Recruiting |
Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis
|
||||
| 33 | Completed |
A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis
|
||||
| 34 | Completed |
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
|
||||
| 35 | Recruiting |
Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes
|
||||
| 36 | Completed |
Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)
|
||||
| 37 | Enrolling by invitation |
Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
|
||||
| 38 | Completed |
Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers
|
||||
| 39 | Completed |
The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
|
||||
| 40 | Unknown † |
Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis
|
† Indicates status has not been verified in more than two years

